Heterogeneous outcomes of liver disease after heart transplantation for a failed Fontan procedure

Fontan‐associated liver disease (FALD) uniformly affects patients with long‐term Fontan physiology. The effect of isolated heart transplant (HT) on the course of FALD post‐HT is not well understood.

[1]  J. Kirklin,et al.  Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients. , 2021, The Journal of thoracic and cardiovascular surgery.

[2]  Y. D'udekem,et al.  Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. , 2019, Circulation.

[3]  Y. Woo,et al.  Short‐term outcomes of en bloc combined heart and liver transplantation in the failing Fontan , 2019, Clinical transplantation.

[4]  C. Canter,et al.  Heterogenerous Outcomes of Liver Disease after Heart Transplantation for a Failed Fontan Procedure , 2019, The Journal of Heart and Lung Transplantation.

[5]  S. Saab,et al.  Heart and heart–liver transplantation in adults with failing Fontan physiology , 2018, Clinical transplantation.

[6]  K. Niwa,et al.  Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure　- A Nationwide Survey in Japan. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[7]  E. Blume,et al.  Liver abnormalities and post‐transplant survival in pediatric Fontan patients , 2017, Pediatric transplantation.

[8]  M. Fogel,et al.  Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study , 2017, Journal of the American Heart Association.

[9]  C. Canter,et al.  Fontan Patient Survival After Pediatric Heart Transplantation Has Improved in the Current Era. , 2017, The Annals of thoracic surgery.

[10]  K. Gauvreau,et al.  Liver health in adults with Fontan circulation: A multicenter cross‐sectional study , 2017, The Journal of thoracic and cardiovascular surgery.

[11]  K. Olthoff,et al.  Single‐center outcomes of combined heart and liver transplantation in the failing Fontan , 2017, Clinical transplantation.

[12]  K. Gauvreau,et al.  Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  J. Rychik,et al.  Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation. , 2016, Human pathology.

[14]  B. Whitson,et al.  Combined heart-liver transplantation: Indications, outcomes and current experience. , 2016, Transplantation reviews.

[15]  Jack Rychik,et al.  The Relentless Effects of the Fontan Paradox. , 2016, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[16]  C. Ukomadu,et al.  Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  C. Canter,et al.  Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  Jack Rychik,et al.  End-organ consequences of the Fontan operation: liver fibrosis, protein-losing enteropathy and plastic bronchitis , 2013, Cardiology in the Young.

[19]  D. Bernstein,et al.  Intermediate-term outcomes after combined heart-liver transplantation in children with a univentricular heart. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  D. Podberesky,et al.  Hepatic pathology after Fontan palliation: spectrum of imaging findings , 2013, Pediatric Radiology.